Raras
Buscar doenças, sintomas, genes...
Gliossarcoma
ORPHA:251576CID-10 · C71.9CID-11 · 2A00.00DOENÇA RARA

Uma variação rara de glioblastoma (um tipo agressivo de tumor cerebral, de grau 4 pela Organização Mundial da Saúde – OMS), que se caracteriza por apresentar um padrão de tecido com duas "partes" diferentes: áreas que se alternam com características de células gliais e de células mesenquimais (segundo a OMS).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma variação rara de glioblastoma (um tipo agressivo de tumor cerebral, de grau 4 pela Organização Mundial da Saúde – OMS), que se caracteriza por apresentar um padrão de tecido com duas "partes" diferentes: áreas que se alternam com características de células gliais e de células mesenquimais (segundo a OMS).

Pesquisas ativas
33 ensaios
503 total registrados no ClinicalTrials.gov
Publicações científicas
1.196 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.03
Europe
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C71.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.196PubMed
Últimos 10 anos200publicações
Pico202336 papers
Linha do tempo
2026Hoje · 2026🧪 1991Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

12 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

TACC1Transforming acidic coiled-coil-containing protein 1Part of a fusion gene inTolerante
FUNÇÃO

Involved in transcription regulation induced by nuclear receptors, including in T3 thyroid hormone and all-trans retinoic acid pathways (PubMed:20078863). Might promote the nuclear localization of the receptors (PubMed:20078863). Likely involved in the processes that promote cell division prior to the formation of differentiated tissues

LOCALIZAÇÃO

CytoplasmNucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeMidbodyMembrane

VIAS BIOLÓGICAS (1)
Signaling by plasma membrane FGFR1 fusions
EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
142.9 TPM
Esôfago - Muscular
140.6 TPM
Útero
124.4 TPM
Esôfago - Junção
122.5 TPM
Tecido adiposo
119.2 TPM
OUTRAS DOENÇAS (2)
giant cell glioblastomagliosarcoma
HGNC:11522UniProt:O75410
LZTR1Leucine-zipper-like transcriptional regulator 1Disease-causing somatic mutation(s) inTolerante
FUNÇÃO

Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates ubiquitination of Ras (K-Ras/KRAS, N-Ras/NRAS and H-Ras/HRAS) (PubMed:30442762, PubMed:30442766, PubMed:30481304). Is a negative regulator of RAS-MAPK signaling that acts by controlling Ras levels and decreasing Ras association with membranes (PubMed:30442762, PubMed:30442766, PubMed:30481304)

LOCALIZAÇÃO

Endomembrane systemRecycling endosomeGolgi apparatus

MECANISMO DE DOENÇA

Glioma

Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
76.5 TPM
Nervo tibial
68.8 TPM
Útero
67.8 TPM
Cervix Ectocervix
65.1 TPM
Cervix Endocervix
61.7 TPM
OUTRAS DOENÇAS (9)
Noonan syndrome 10RASopathyNoonan syndrome 2cafe au lait spots, multiple
HGNC:6742UniProt:Q8N653
FGFR3Fibroblast growth factor receptor 3Part of a fusion gene inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferat

LOCALIZAÇÃO

Cell membraneCytoplasmic vesicleEndoplasmic reticulumSecreted

VIAS BIOLÓGICAS (2)
Signaling by FGFR3 in diseaset(4;14) translocations of FGFR3
MECANISMO DE DOENÇA

Achondroplasia

A frequent form of short-limb dwarfism. It is characterized by a long, narrow trunk, short extremities, particularly in the proximal (rhizomelic) segments, a large head with frontal bossing, hypoplasia of the midface and a trident configuration of the hands. ACH is an autosomal dominant disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
364.6 TPM
Skin Sun Exposed Lower leg
356.5 TPM
Esôfago - Mucosa
199.7 TPM
Brain Caudate basal ganglia
148.4 TPM
Brain Nucleus accumbens basal ganglia
135.4 TPM
OUTRAS DOENÇAS (19)
nevus, epidermalsevere achondroplasia-developmental delay-acanthosis nigricans syndromelacrimoauriculodentodigital syndrome 2testicular germ cell tumor
HGNC:3690UniProt:P22607
TP53Cellular tumor antigen p53Biomarker tested inAltamente restrito
FUNÇÃO

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apop

LOCALIZAÇÃO

CytoplasmNucleusNucleus, PML bodyEndoplasmic reticulumMitochondrion matrixCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (10)
TP53 Regulates Metabolic GenesRegulation of TP53 ExpressionRegulation of TP53 DegradationOncogene Induced SenescenceOxidative Stress Induced Senescence
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
73.0 TPM
Skin Sun Exposed Lower leg
37.0 TPM
Skin Not Sun Exposed Suprapubic
35.2 TPM
Fibroblastos
32.9 TPM
Ovário
32.4 TPM
OUTRAS DOENÇAS (29)
Li-Fraumeni syndromenasopharyngeal carcinoma, susceptibility to, 1hepatocellular carcinomafamilial pancreatic carcinoma
HGNC:11998UniProt:P04637
MGMTMethylated-DNA--protein-cysteine methyltransferaseBiomarker tested inTolerante
FUNÇÃO

Involved in the cellular defense against the biological effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT) in DNA. Repairs the methylated nucleobase in DNA by stoichiometrically transferring the methyl group to a cysteine residue in the enzyme. This is a suicide reaction: the enzyme is irreversibly inactivated

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
MGMT-mediated DNA damage reversal
EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
38.0 TPM
Testículo
25.7 TPM
Tecido adiposo
25.1 TPM
Mama
24.2 TPM
Bladder
23.6 TPM
OUTRAS DOENÇAS (3)
gliosarcomafamilial melanomagiant cell glioblastoma
HGNC:7059UniProt:P16455
PPARGPeroxisome proliferator-activated receptor gammaBiomarker tested inModerado
FUNÇÃO

Ligand-activated transcription factor that forms obligate heterodimers with the retinoic acid receptor and acts as a key regulator of biological processes, such as adipocyte differentiation, lipid metabolism, glucose homeostasis and beta-oxidation of fatty acids (PubMed:16150867, PubMed:20829347, PubMed:23525231, PubMed:8702406, PubMed:8706692, PubMed:9065481). Activated by lipid ligands: binds peroxisome proliferators, such as hypolipidemic drugs, and fatty acids, such as prostaglandin J2 metab

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (7)
Regulation of PTEN gene transcriptionTranscriptional regulation of white adipocyte differentiationPPARA activates gene expressionMECP2 regulates transcription factorsNuclear Receptor transcription pathway
EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
111.2 TPM
Adipose Visceral Omentum
100.8 TPM
Mama
71.3 TPM
Cólon transverso
21.6 TPM
Fibroblastos
20.4 TPM
OUTRAS DOENÇAS (6)
type 2 diabetes mellitusPPARG-related familial partial lipodystrophyinherited obesitygliosarcoma
HGNC:9236UniProt:P37231
NFKBIANF-kappa-B inhibitor alphaBiomarker tested inAltamente restrito
FUNÇÃO

Inhibits the activity of dimeric NF-kappa-B/REL complexes by trapping REL (RELA/p65 and NFKB1/p50) dimers in the cytoplasm by masking their nuclear localization signals (PubMed:1493333, PubMed:36651806, PubMed:7479976). On cellular stimulation by immune and pro-inflammatory responses, becomes phosphorylated promoting ubiquitination and degradation, enabling the dimeric RELA to translocate to the nucleus and activate transcription (PubMed:7479976, PubMed:7628694, PubMed:7796813, PubMed:7878466)

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
RIP-mediated NFkB activation via ZBP1TRAF6 mediated NF-kB activationTAK1-dependent IKK and NF-kappa-B activation NF-kB is activated and signals survivalCLEC7A (Dectin-1) signaling
MECANISMO DE DOENÇA

Ectodermal dysplasia and immunodeficiency 2

A form of ectoderma dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. This form of ectodermal dysplasia is associated with decreased production of pro-inflammatory cytokines and certain interferons, rendering patients susceptible to infection. EDAID2 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
497.5 TPM
Nervo tibial
450.8 TPM
Baço
352.8 TPM
Ovário
332.9 TPM
Skin Not Sun Exposed Suprapubic
320.1 TPM
OUTRAS DOENÇAS (5)
ectodermal dysplasia and immunodeficiency 2ectodermal dysplasia and immune deficiencygiant cell glioblastomanasopharyngeal carcinoma
HGNC:7797UniProt:P25963
IDH1Isocitrate dehydrogenase [NADP] cytoplasmicBiomarker tested inTolerante
FUNÇÃO

Catalyzes the NADP(+)-dependent oxidative decarboxylation of isocitrate (D-threo-isocitrate) to 2-ketoglutarate (2-oxoglutarate), which is required by other enzymes such as the phytanoyl-CoA dioxygenase (PubMed:10521434, PubMed:19935646). Plays a critical role in the generation of NADPH, an important cofactor in many biosynthesis pathways (PubMed:10521434). May act as a corneal epithelial crystallin and may be involved in maintaining corneal epithelial transparency (By similarity)

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome

VIAS BIOLÓGICAS (3)
NADPH regenerationNFE2L2 regulating TCA cycle genesPeroxisomal protein import
MECANISMO DE DOENÇA

Glioma

Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
266.5 TPM
Fígado
100.4 TPM
Esôfago - Mucosa
99.8 TPM
Tecido adiposo
81.8 TPM
Próstata
77.7 TPM
OUTRAS DOENÇAS (7)
Maffucci syndromemetaphyseal chondromatosis with D-2-hydroxyglutaric aciduriaacute myeloid leukemia with multilineage dysplasiaOllier disease
HGNC:5382UniProt:O75874
EGFREpidermal growth factor receptorPart of a fusion gene inRestrito
FUNÇÃO

Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:10805725, PubMed:27153536, PubMed:2790960, PubMed:35538033). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:12297049, PubMed:15611079, PubMed:17909029, PubMed:20837704, PubMed:27153536, PubMed:2790960, PubMed:7679104, PubMed:8144591, PubM

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneGolgi apparatus membraneNucleus membraneEndosomeEndosome membraneNucleusSecreted

VIAS BIOLÓGICAS (10)
Signaling by EGFRInhibition of Signaling by Overexpressed EGFRSignaling by ERBB2Signaling by ERBB4Signaling by ERBB2 TMD/JMD mutants
MECANISMO DE DOENÇA

Lung cancer

A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
78.3 TPM
Skin Not Sun Exposed Suprapubic
75.9 TPM
Fibroblastos
60.6 TPM
Nervo tibial
43.1 TPM
Vagina
40.6 TPM
OUTRAS DOENÇAS (4)
inflammatory skin and bowel disease, neonatal, 2lung cancergliosarcomagiant cell glioblastoma
HGNC:3236UniProt:P00533
TACC3Transforming acidic coiled-coil-containing protein 3Part of a fusion gene inTolerante
FUNÇÃO

Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). Acts as a component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. The TACC3/ch-TOG/clathrin complex is required for the maintenance of kinetochore fiber tension (P

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle pole

VIAS BIOLÓGICAS (2)
Negative regulation of NOTCH4 signalingNOTCH3 Activation and Transmission of Signal to the Nucleus
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
122.0 TPM
Linfócitos
98.8 TPM
Sangue
80.8 TPM
Baço
44.0 TPM
Fibroblastos
29.4 TPM
OUTRAS DOENÇAS (2)
giant cell glioblastomagliosarcoma
HGNC:11524UniProt:Q9Y6A5
SEPTIN14Septin-14Part of a fusion gene inTolerante
FUNÇÃO

Filament-forming cytoskeletal GTPase (Probable). Involved in the migration of cortical neurons and the formation of neuron leading processes during embryonic development (By similarity). Plays a role in sperm head formation during spermiogenesis, potentially via facilitating localization of ACTN4 to cell filaments (PubMed:33228246)

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonCell projection, axonCell projection, dendritePerikaryonCytoplasm, perinuclear regionCytoplasmic vesicle, secretory vesicle, acrosome

OUTRAS DOENÇAS (2)
gliosarcomagiant cell glioblastoma
HGNC:33280UniProt:Q6ZU15
FGFR1Fibroblast growth factor receptor 1Part of a fusion gene inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activati

LOCALIZAÇÃO

Cell membraneNucleusCytoplasm, cytosolCytoplasmic vesicle

VIAS BIOLÓGICAS (2)
Epithelial-Mesenchymal Transition (EMT) during gastrulationFormation of paraxial mesoderm
MECANISMO DE DOENÇA

Pfeiffer syndrome

A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3).

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
144.8 TPM
Ovário
142.9 TPM
Artéria tibial
134.1 TPM
Fallopian Tube
122.3 TPM
Cérebro - Hemisfério cerebelar
122.0 TPM
OUTRAS DOENÇAS (20)
Hartsfield-Bixler-Demyer syndromeencephalocraniocutaneous lipomatosisosteoglophonic dysplasiaPfeiffer syndrome
HGNC:3688UniProt:P11362

Variantes genéticas (ClinVar)

628 variantes patogênicas registradas no ClinVar.

🧬 FGFR1: NM_023110.3(FGFR1):c.2156T>C (p.Met719Thr) ()
🧬 FGFR1: NM_023110.3(FGFR1):c.570del (p.Trp190fs) ()
🧬 FGFR1: NM_023110.3(FGFR1):c.74del (p.Pro25fs) ()
🧬 FGFR1: NM_023110.3(FGFR1):c.494del (p.Leu165fs) ()
🧬 FGFR1: NM_023110.3(FGFR1):c.831dup (p.Lys278Ter) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

117 vias biológicas associadas aos genes desta condição.

Signaling by plasma membrane FGFR1 fusions PI3K Cascade PIP3 activates AKT signaling Signaling by activated point mutants of FGFR3 FGFR3b ligand binding and activation FGFR3c ligand binding and activation t(4;14) translocations of FGFR3 Constitutive Signaling by Aberrant PI3K in Cancer Phospholipase C-mediated cascade; FGFR3 SHC-mediated cascade:FGFR3 FRS-mediated FGFR3 signaling PI-3K cascade:FGFR3 Negative regulation of FGFR3 signaling Signaling by FGFR3 in disease RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Signaling by FGFR3 fusions in cancer Activation of NOXA and translocation to mitochondria Activation of PUMA and translocation to mitochondria Pre-NOTCH Transcription and Translation Oxidative Stress Induced Senescence Formation of Senescence-Associated Heterochromatin Foci (SAHF) Oncogene Induced Senescence DNA Damage/Telomere Stress Induced Senescence SUMOylation of transcription factors Autodegradation of the E3 ubiquitin ligase COP1 Association of TriC/CCT with target proteins during biosynthesis Pyroptosis TP53 Regulates Metabolic Genes Ub-specific processing proteases Ovarian tumor domain proteases Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Interleukin-4 and Interleukin-13 signaling TP53 Regulates Transcription of DNA Repair Genes TP53 Regulates Transcription of Genes Involved in Cytochrome C Release TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain TP53 Regulates Transcription of Caspase Activators and Caspases TP53 Regulates Transcription of Death Receptors and Ligands TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest Regulation of TP53 Expression Regulation of TP53 Activity through Phosphorylation Regulation of TP53 Degradation Regulation of TP53 Activity through Acetylation Regulation of TP53 Activity through Association with Co-factors Regulation of TP53 Activity through Methylation MGMT-mediated DNA damage reversal PPARA activates gene expression Transcriptional regulation of white adipocyte differentiation Nuclear Receptor transcription pathway SUMOylation of intracellular receptors Regulation of PTEN gene transcription MECP2 regulates transcription factors MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 Activation of NF-kappaB in B cells RIP-mediated NFkB activation via ZBP1 Downstream TCR signaling NF-kB is activated and signals survival FCERI mediated NF-kB activation TAK1-dependent IKK and NF-kappa-B activation SUMOylation of immune response proteins IkBA variant leads to EDA-ID CLEC7A (Dectin-1) signaling Interleukin-1 signaling TRAF6 mediated NF-kB activation SARS-CoV-1 activates/modulates innate immune responses Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells Dengue virus modulates apoptosis Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate NADPH regeneration Neutrophil degranulation Peroxisomal protein import NFE2L2 regulating TCA cycle genes Signaling by ERBB2 Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants Signaling by ERBB4 SHC1 events in ERBB2 signaling PLCG1 events in ERBB2 signaling Signaling by EGFR GRB2 events in EGFR signaling GAB1 signalosome SHC1 events in EGFR signaling EGFR downregulation GRB2 events in ERBB2 signaling PI3K events in ERBB2 signaling EGFR interacts with phospholipase C-gamma EGFR Transactivation by Gastrin Signal transduction by L1 Constitutive Signaling by EGFRvIII Inhibition of Signaling by Overexpressed EGFR ERBB2 Regulates Cell Motility ERBB2 Activates PTK6 Signaling Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis PTK6 promotes HIF1A stabilization Downregulation of ERBB2 signaling TFAP2 (AP-2) family regulates transcription of growth factors and their receptors Extra-nuclear estrogen signaling NOTCH3 Activation and Transmission of Signal to the Nucleus Negative regulation of NOTCH4 signaling Signaling by FGFR1 amplification mutants Signaling by activated point mutants of FGFR1 FGFR1b ligand binding and activation FGFR1c ligand binding and activation FGFR1c and Klotho ligand binding and activation NCAM signaling for neurite out-growth Phospholipase C-mediated cascade: FGFR1 Downstream signaling of activated FGFR1 SHC-mediated cascade:FGFR1 PI-3K cascade:FGFR1 FRS-mediated FGFR1 signaling Negative regulation of FGFR1 signaling Signaling by FGFR1 in disease Epithelial-Mesenchymal Transition (EMT) during gastrulation Formation of paraxial mesoderm

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 27
1Fase 110
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Gliossarcoma

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

17 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT05698524 · A Study of Temodar With Abexinostat (PCI-24781) for Patients…Recrutando
PHASE1
NCT07134842 · A Study Assessing if it is Safe and Possible to Treat Brain …Recrutando
PHASE1
NCT07301268 · GI-102 Alone or With Pembrolizumab Before Surgery for Treatm…Recrutando
PHASE2
NCT06934889 · Study of ABBV-637 or ABBV-155 With ERAS-801 for People With …Recrutando
PHASE1
NCT03896568 · MSC-DNX-2401 in Treating Patients With Recurrent High-Grade …Recrutando
PHASE1
NCT05756985 · Improving Understanding of Glioblastoma Through Preservation…Recrutando
NCT04991870 · Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBMRecrutando
PHASE1
NCT05084430 · Study of Pembrolizumab and M032 (NSC 733972)Recrutando
PHASE1, PHASE2
NCT05465954 · Efineptakin Alfa and Pembrolizumab for the Treatment of Recu…Recrutando
PHASE2
NCT05039281 · Atezolizumab and Cabozantinib for the Treatment of Recurrent…Recrutando
PHASE1, PHASE2
NCT04541082 · Phase I Study of Oral ONC206 in Recurrent and Rare Primary C…Recrutando
PHASE1
NCT05052957 · hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)Recrutando
PHASE2
NCT04555577 · Peposertib and Radiation Therapy, Followed by Temozolomide f…Recrutando
PHASE1
NCT05864534 · Phase 2a Immune Modulation With Ultrasound for Newly Diagnos…Recrutando
PHASE2
NCT05857969 · Ex Vivo Drug Sensitivity Testing and Multi-Omics ProfilingRecrutando
PHASE1
NCT06954636 · Prognostic Potential of Olfactory Function in Glioblastoma: …Recrutando
NCT06896110 · Intrathecal Azacitidine and Nivolumab in Patients With Recur…Por convite
PHASE1

Outros ensaios clínicos

503 ensaios clínicos encontrados, 33 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
347 papers (10 anos)
#1

Clinical and molecular features of primary gliosarcoma with digital spatial whole-transcriptome analysis of glial and mesenchymal components.

Brain pathology (Zurich, Switzerland)2026 Mar 18

Gliosarcoma is a rare subtype of IDH-wildtype glioblastoma defined by mixed malignant glial and high-grade sarcomatous histological elements. Gliosarcoma is clinically managed similarly to glioblastoma and has a poor outcome. The sarcoma-like regions of gliosarcoma are thought to represent extreme mesenchymal metaplasia of neoplastic glial cells. Factors contributing to this phenomenon are not completely understood. Here we report a single-institution series of 37 gliosarcomas including next-generation sequencing data on 25 cases and digital spatial whole-transcriptome analysis on four cases to characterize differential gene expression between glial and mesenchymal components. Gliosarcoma demographic and genetic features were compared to a cohort of 75 primary adult hemispheric IDH-wildtype non-sarcomatous glioblastomas. Patient age, tumor location, sex, and overall survival in gliosarcoma were similar to glioblastoma. Gliosarcomas showed a significantly lower rate of EGFR amplification and a higher rate of NF1 mutation compared to glioblastomas in next-generation sequencing analysis. Digital spatial whole-transcriptome analysis showed a distinct transcriptomic profile in sarcomatous regions with over-expression of genes involved in extracellular matrix development and remodeling. Selected differentially expressed transcripts were examined further by immunohistochemistry. The glial elements of gliosarcomas showed higher immunoreactivity for Chitinase-3-like protein 1 (CHI3L1) than glioblastomas, and low to absent immunoreactivity within the sarcomatous elements. Lymphoid Enhancer-Binding Factor 1 (LEF1) immunoreactivity was identified within sarcomatous regions of gliosarcoma without detectable nuclear β-catenin, suggesting a role for β-catenin independent wingless (WNT) effector signaling in sarcomatous transformation. This study adds to the growing literature demonstrating differences in the genetic underpinning of gliosarcoma and glioblastoma, establishes feasibility of spatial transcriptomic approaches in gliosarcoma, and builds on digital spatial profiling-based results as a discovery platform to identify pathways and immunohistochemical markers for further study.

#2

Gliosarcoma: A Reappraisal of Neuroradiological, Surgical, Morphological, and Radiotherapeutic Characteristics of a Cohort From South Italy Single-Center.

Analytical cellular pathology (Amsterdam)2026

Gliosarcoma (GS) is a rare and aggressive variant of glioblastoma multiforme (GBM), characterized by a biphasic histopathological pattern featuring both glial and mesenchymal components. Accounting for 2% of all GBM cases, this brain tumor is known for its poor prognosis, rapid progression, and resistance to conventional treatments. Despite advances in molecular profiling and multimodal treatment strategies, GS remains a therapeutic challenge due to their highly invasive nature and limited response to standard regimens. The purpose of this study was to characterize the neuroradiological, surgical, clinicopathological, and radiotherapeutic profiles of a cohort of patients affected by GS, including two recurrences of disease.

#3

Molecular analysis of a gliosarcoma with distinct oligodendroglioma and sarcomatous components ("Oligosarcoma").

Brain tumor pathology2026 Mar 15
#4

Gliosarcoma of the right cerebellar hemisphere and parahippocampal region: A case report and literature review.

Oncology letters2026 Apr

Intracranial gliosarcoma (GSM) is a rare and aggressive variant of glioblastoma, characterized by a dismal prognosis and high rates of early recurrence and metastasis. Preoperative differentiation from other neoplasms based on imaging features remains a significant clinical challenge. The current study reports the case of a 55-year-old female who presented with a headache as the primary clinical symptom. The patient underwent brain MRI due to progressively worsening symptoms of diplopia, intermittent dull headaches localized to the right occipital region and an unsteady gait. Preoperative magnetic resonance imaging revealed a large, lobulated mass in the right cerebellar hemisphere extending into the parahippocampal region. The diagnosis of WHO Grade IV GSM was confirmed by postoperative histopathological and immunohistochemical analysis, which revealed a biphasic pattern with glial fibrillary acidic protein-positive glial and smooth muscle actin/vimentin-positive sarcomatous components, alongside a high Ki-67 proliferation index of 30%. The patient underwent a subtotal resection followed by adjuvant radiotherapy with concurrent temozolomide chemotherapy. Despite this multimodal treatment, follow-up imaging demonstrated tumor recurrence at 2 months, with significant further progression and brain herniation observed at the 12-month follow-up. The present case underscores the diagnostic challenges and aggressive clinical course of GSM, particularly when located in the cerebellum. The rapid recurrence despite combined-modality therapy highlights the need for improved diagnostic strategies and more effective treatment protocols for this formidable disease.

#5

Gelatin hydrogel cross-linked with glutaraldehyde loaded with methylene blue for photodynamic action in gliosarcoma strain 9 L/lacZ.

Journal of biomaterials applications2026 Mar 02

Since the prognosis and treatment of nervous system tumors are still not beneficial to the patient, alternative therapies need to be investigated as primary or supplemental treatments to current methods. Hydrogel systems are well-known for their high-water absorption capacity, three-dimensional network composition, and biocompatibility, making them suitable as photosensitizers (PS) carriers for photodynamic therapy (PDT). A gelatin hydrogel system was synthesized via chemical cross-linking with varying glutaraldehyde concentrations, and the optimal hydrogel was encapsulated with methylene blue (MB). Scanning electron microscopy (SEM) analysis demonstrated that the formulation formed three-dimensional networks. The freeze-drying procedure increases the hydrogel's water-retention capacity, as shown by the swelling test. All spectroscopic results showed excellent photophysical properties of MB when incorporated into the system. The encapsulation efficiency was 95.35%. According to the trypan blue exclusion test, the cell viability in the PDT-treated groups was significantly lower (p < 0.05). Approximately 95% of 9 L/lacZ cells died after PDT utilizing a concentration of 50 μmol.mL-1 for the hydrogel with MB. Based on the data obtained, the system's viability has been confirmed, and it is expected to demonstrate potential in the treatment of neoplasms.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC556 artigos no totalmostrando 197

2026

Clinical and molecular features of primary gliosarcoma with digital spatial whole-transcriptome analysis of glial and mesenchymal components.

Brain pathology (Zurich, Switzerland)
2026

Molecular analysis of a gliosarcoma with distinct oligodendroglioma and sarcomatous components ("Oligosarcoma").

Brain tumor pathology
2026

Gliosarcoma: A Reappraisal of Neuroradiological, Surgical, Morphological, and Radiotherapeutic Characteristics of a Cohort From South Italy Single-Center.

Analytical cellular pathology (Amsterdam)
2026

Gliosarcoma of the right cerebellar hemisphere and parahippocampal region: A case report and literature review.

Oncology letters
2026

Gelatin hydrogel cross-linked with glutaraldehyde loaded with methylene blue for photodynamic action in gliosarcoma strain 9 L/lacZ.

Journal of biomaterials applications
2026

Gliosarcoma: A Case Series and Comprehensive Literature Review.

Cureus
2025

Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma.

medRxiv : the preprint server for health sciences
2026

Distal noncontiguous recurrence and sarcomatous transformation of glioblastoma with stable molecular profile: illustrative case.

Journal of neurosurgery. Case lessons
2026

A unified framework integrating local effect and DNA damage for the derivation of cell survival model parameters.

International journal of radiation biology
2025

Glioblastoma zebrafish Avatars guide therapeutic decisions in a patient with gliosarcoma: a case report.

Communications medicine
2025

Primary Intracranial Sarcoma, DICER1-Mutant, Diagnosed by DNA Methylation Profiling in an Adult Patient with Germline DICER1 Mutation: A Case Report.

International journal of surgical pathology
2026

Maternal Neurosurgical Management of Central Nervous System Tumors During Pregnancy: A Case Series with Long-Term Offspring Neurodevelopmental Follow-Up.

World neurosurgery
2026

An Exploratory Application of a Central Nervous System (CNS) Tumor Methylation Classifier in Ovarian Neuroectodermal Tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2025

Diagnostic challenges of gliosarcoma: case report of a rare glioblastoma histopathological variant.

Frontiers in radiology
2025

When is A Kidney Biopsy Indicated During the Treatment of Brain Cancer?

European journal of case reports in internal medicine
2025

Photodynamic treatment in glioma: Metabolic and structural evaluation after therapy.

Photochemistry and photobiology
2026

Clinical, radiological, and molecular insights into extracranial metastases from adult gliomas.

Neuro-oncology
2025

Tumor microenvironment-preserving gliosarcoma organoids as an in vitro preclinical platform: a comparative analysis with glioblastoma models.

Journal of translational medicine
2025

Rare osseous mastoid invasion of secondary gliosarcoma: illustrative case.

Journal of neurosurgery. Case lessons
2025

A Challenging Diagnosis of Gliosarcoma: A Case Report.

Cureus
2025

Magnetic Resonance Imaging for Improved Brain Tumor Detection.

bioRxiv : the preprint server for biology
2025

Combinational Radiotherapies Improve Brain Cancer Treatment at High Dose Rates In Vitro.

Cancers
2025

Next generation sequencing unravels a gliosarcoma mimicking cerebral osteosarcoma.

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
2025

Three-dimensional bioprinted in vitro glioma tumor constructs for synchrotron microbeam radiotherapy dosimetry and biological study using gelatin methacryloyl hydrogel.

Scientific reports
2025

Ependymosarcoma presenting as recurrence in a primary left parieto-occipital ependymoma.

Indian journal of pathology &amp; microbiology
2025

A rare case of gliosarcoma: Comprehensive radiological, histopathological, and clinical insights into diagnosis and management.

Radiology case reports
2025

Oligosarcoma with chondroid metaplasia in a French bulldog.

The Journal of veterinary medical science
2025

Molecular Characteristics of a ZFTA::RELA Fusion Gliosarcoma: A Case Report.

International journal of surgical pathology
2025

Enhancing brain tumor surgery precision with multimodal connectome imaging: Structural and functional connectivity in language-dominant areas.

Clinical neurology and neurosurgery
2025

Do clinical outcomes in individuals with malignant gliomas differ between sexes?

Brain &amp; spine
2025

Repeated 5-aminolevulinic acid mediated sonodynamic therapy using magnetic resonance guided focused ultrasound in rat brain tumour models.

Scientific reports
2025

A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma.

Journal of neuro-oncology
2025

Unsupervised clustering reveals noncanonical myeloid cell subsets in the brain tumor microenvironment.

Cancer immunology, immunotherapy : CII
2025

Secondary IDH-mutant gliosarcoma in a patient with prior IDH-mutant grade 2 astrocytoma.

Journal of neuropathology and experimental neurology
2025

A case of right fronto-parietal gliosarcoma.

Radiology case reports
2024

Primary Gliosarcoma: A 15-Year Experience at a Tertiary Care Center.

Neurology India
2023

Label- and slide-free tissue histology using 3D epi-mode quantitative phase imaging and virtual hematoxylin and eosin staining.

Optica
2024

Radiation-induced malignancies after stereotactic radiosurgery for brain arteriovenous malformations: a large single-center retrospective study and systematic review.

Neurosurgical review
2025

Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.

Neuro-oncology
2024

Ultrasound inhibits tumor growth and selectively eliminates malignant brain tumor in vivo.

Bioengineering &amp; translational medicine
2024

Gliosarcoma: A Multi-Institutional Analysis on Clinical Outcomes and Prognostic Factors.

Cancer medicine
2025

Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastoma.

Journal of neuro-oncology
2024

Conditional survival and changing risk profile in patients with gliosarcoma.

Frontiers in medicine
2024

Gliosarcoma associated with bilateral hippocampal sclerosis in a cat presenting complex partial seizures with orofacial involvement: A case report.

Clinical case reports
2024

Prognostic Factors for Patients with Primary Gliosarcoma: A Single-Center Retrospective Study.

World neurosurgery
2024

Differentiating Gliosarcoma from Glioblastoma: A Novel Approach Using PEACE and XGBoost to Deal with Datasets with Ultra-High Dimensional Confounders.

Life (Basel, Switzerland)
2024

Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.

JCO precision oncology
2024

The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68Ga-FAPI-46 PET Data, and Survival Data.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2024

Metastatic glioblastoma to the lungs: a case report and literature review.

CNS oncology
2024

A case report: Gliosarcoma associated with a germline heterozygous mutation in MSH2.

Frontiers in neurology
2024

Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.

Folia neuropathologica
2024

Translational research of boron neutron capture therapy for spinal cord gliomas using rat model.

Scientific reports
2024

Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.

PloS one
2024

TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma.

Neuro-oncology advances
2024

Giant cell glioblastoma with lipogenic differentiation in a patient with neurofibromatosis type 1: A case report.

Neuropathology : official journal of the Japanese Society of Neuropathology
2023

Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics.

Journal of clinical medicine
2024

Competing Risk Model to Determine the Prognostic Factors for Patients with Gliosarcoma.

World neurosurgery
2023

An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile.

Nagoya journal of medical science
2023

Introducing Albumin and Interleukin 6 as Common Critical Dysregulated Proteins Between Migraine and Gliosarcoma.

Basic and clinical neuroscience
2024

PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2023

RAR-Dependent and RAR-Independent RXR Signaling in Stem-like Glioma Cells.

International journal of molecular sciences
2023

Pediatric gliosarcoma, a rare central nervous system tumor in children: Case report and literature review.

Heliyon
2023

Freiburg Neuropathology Case Conference : Headache, Mental Confusion and Mild Hemiparesis in a 68-year-old Patient.

Clinical neuroradiology
2023

Hydroxyapatite microspheres used as a drug delivery system for gliosarcoma strain 9l/Lacz treatment by photodynamic therapy protocols.

Photodiagnosis and photodynamic therapy
2023

TERTmonitor-qPCR Detection of TERTp Mutations in Glioma.

Genes
2024

Cytological features of diffuse and circumscribed gliomas.

Cytopathology : official journal of the British Society for Clinical Cytology
2023

Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.

The Lancet. Oncology
2023

A Novel Setup Technique for Radiation Treatment of a Severely Obese Patient With a Primary Brain Tumor.

Cureus
2023

Gliosarcoma Invading the Temporal Bone, Temporalis Muscle, and Skull Base.

Cureus
2023

Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.

JAMA dermatology
2023

Bilateral Central Retinal Vein Occlusion in Recurrent Frontal Lobe Tumor.

Cureus
2023

Venous ectasia preceding intra-tumoral hemorrhage in a case of gliosarcoma with transverse sinus involvement.

Journal of surgical case reports
2023

Calculation of the DNA damage yield and relative biological effectiveness in boron neutron capture therapy via the Monte Carlo track structure simulation.

Physics in medicine and biology
2023

Clinicopathological and Neuroimaging Features of Primary Gliosarcoma: A Case Series and Review of Literature.

World neurosurgery
2023

Unusual extraneural metastasis of glioblastoma.

Surgical neurology international
2023

Label- and slide-free tissue histology using 3D epi-mode quantitative phase imaging and virtual H&E staining.

ArXiv
2023

Intracranial Gliosarcoma: A National Cancer Database Survey of Clinical Predictors for Overall Survival.

World neurosurgery
2023

A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.

Ophthalmic research
2023

Prostate-Specific Membrane Antigen (PSMA) Expression in The Neovasculature of High Grade Gliomas (Histopathological and Immunohistochemical Study).

Asian Pacific journal of cancer prevention : APJCP
2023

Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma.

NPJ precision oncology
2023

Metastatic secondary gliosarcoma: patient series.

Journal of neurosurgery. Case lessons
2023

Extracranial Glioblastoma Metastasis: A Neuropathological Case Report.

Cureus
2023

Radiation-induced intracranial rhabdomyosarcoma- A rare complication: Report of a case with literature review.

Medical journal, Armed Forces India
2023

Gliosarcoma with extensive extracranial metastatic spread and familial coincidence: A case report.

Pathology, research and practice
2023

A Rare Tumor in a Rare Location: Radiology and Pathology Findings With a Literature Review on Intraventricular Gliosarcoma.

Cureus
2023

A Novel Case of Primary Conus Medullaris Epithelioid Glioblastoma with Gliosarcomatous Differentiation.

Neurology India
2023

Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.

Neuro-oncology
2022

Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature.

Frontiers in oncology
2023

Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.

Computational and mathematical methods in medicine
2023

Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.

Scientific reports
2023

A rare, giant, lateral intraventricular gliosarcoma.

Radiology case reports
2022

Computed Tomography, Magnetic Resonance Imaging, and Pathological Features of Gliosarcoma.

Neuropsychiatric disease and treatment
2023

Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study.

EClinicalMedicine
2022

Optimization of a flexible fiber-optic probe for epi-mode quantitative phase imaging.

Optics express
2022

Towards differentiation of brain tumor from radiation necrosis using multi-parametric MRI: Preliminary results at 4.7 T using rodent models.

Magnetic resonance imaging
2022

Gliosarcoma with Systemic Metastasis Showing Favorable Response to Ifosfamide, Carboplatin, and Etoposide Chemotherapy: An Autopsy Case Report.

NMC case report journal
2023

Rodent Brain Tumor Models for Studies Focusing on Boron Neutron Capture Therapy.

Cancer biotherapy &amp; radiopharmaceuticals
2022

Multidisciplinary approaches to gliosarcoma: A case report and review of the literature.

Clinical case reports
2022

Gliosarcoma With Glioneuronal and Rhabdomyosarcoma Components.

Cureus
2022

Primary gliosarcoma with widespread extracranial metastases-spatiotemporal morphological variation.

Chinese neurosurgical journal
2022

Ketogenic Metabolic Therapy for Glioma.

Cureus
2022

Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.

Revue neurologique
2022

Primary versus secondary gliosarcoma: a systematic review and meta-analysis.

Journal of neuro-oncology
2022

Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.

Analytical cellular pathology (Amsterdam)
2022

Gliosarcoma with unusual glial components: Two case reports.

Neuropathology : official journal of the Japanese Society of Neuropathology
2022

Glioblastoma: Changing concepts in the WHO CNS5 classification.

Indian journal of pathology &amp; microbiology
2022

Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients.

Journal of neuro-oncology
2022

Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.

Journal of neuropathology and experimental neurology
2022

Primary intramedullary spinal gliosarcoma: An unusual presentation.

Journal of cancer research and therapeutics
2022

Can a signature molecular-profile define disparate survival in BRAF-positive Gliosarcoma and identify novel targets for therapeutic intervention?

Journal of cancer research and therapeutics
2022

Gliosarcoma with osteosarcomatous component: A case report and short review illustration.

Pathology, research and practice
2022

Meloxicam can Potentiate the Therapeutic Effects of Synchrotron Microbeam Radiation Therapy on High-Grade Glioma Bearing Rats.

Radiation research
2022

Gliosarcoma with direct involvement of the oculomotor nerve: Case report and literature review.

Radiology case reports
2022

Distinct metabolic hallmarks of WHO classified adult glioma subtypes.

Neuro-oncology
2022

Sarcomatous Change of Cerebellopontine Angle Ependymoma Following Radiosurgery: A Case Report.

Cureus
2022

Clinical and survival characteristics of primary and secondary gliosarcoma patients.

Clinical neurology and neurosurgery
2022

A Unique Case Report of Infant-Type Hemispheric Glioma (Gliosarcoma Subtype) with TPR-NTRK1 Fusion Treated with Larotrectinib.

Pathobiology : journal of immunopathology, molecular and cellular biology
2022

CNS Histoplasmosis as a Gliosarcoma mimicker: The diagnostic dilemma of solitary brain lesions.

IDCases
2022

Primary intraventricular gliosarcoma on MRI: A challenging diagnosis.

Radiology case reports
2022

Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma model.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2022

Oligosarcomas, IDH-mutant are distinct and aggressive.

Acta neuropathologica
2022

Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcoma.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
2021

GammaTile for Gliomas: A Single-Center Case Series.

Cureus
2021

Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database.

Frontiers in neurology
2022

Photodynamic effect of protoporphyrin IX in gliosarcoma 9l/lacZ cell line.

Photodiagnosis and photodynamic therapy
2022

Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.

Laboratory investigation; a journal of technical methods and pathology
2021

Corrigendum: Machine Learning-Based Analysis of Magnetic Resonance Radiomics for the Classification of Gliosarcoma and Glioblastoma.

Frontiers in oncology
2021

Genetic alteration and clonal evolution of primary glioblastoma into secondary gliosarcoma.

CNS neuroscience &amp; therapeutics
2021

Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study.

International journal of clinical oncology
2022

Zinc pthalocyanine loaded poly (lactic acid) nanoparticles by double emulsion methodology for photodynamic therapy against 9 L/LacZ gliosarcoma cells.

Journal of biomaterials science. Polymer edition
2021

Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.

Scientific reports
2021

Machine Learning-Based Analysis of Magnetic Resonance Radiomics for the Classification of Gliosarcoma and Glioblastoma.

Frontiers in oncology
2021

Label-free detection of brain tumors in a 9L gliosarcoma rat model using stimulated Raman scattering-spectroscopic optical coherence tomography.

Journal of biomedical optics
2021

Multidisciplinary Team Effort Results in Better Outcomes in Critically Ill Obstetric Patients Admitted in ICU.

Mymensingh medical journal : MMJ
2021

Captopril inhibits Matrix Metalloproteinase-2 and extends survival as a temozolomide adjuvant in an intracranial gliosarcoma model.

Clinical neurology and neurosurgery
2021

Gliosarcoma with PNET features mimicking a metastatic neuroendocrine carcinoma: A diagnostic dilemma.

Clinical neuropathology
2021

Raman imaging and statistical methods for analysis various type of human brain tumors and breast cancers.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
2021

Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.

BMC neurology
2021

Synthesis, Radiolabeling, and Biological Evaluation of the trans-Stereoisomers of 1-Amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents.

ACS pharmacology &amp; translational science
2021

A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center.

Neuro-oncology practice
2021

Optic pathway gliosarcoma: A very rare location for a rare disease.

Radiology case reports
2021

Co-Occurrence Conundrum: Brain Metastases from Lung Adenocarcinoma, Radiation Necrosis, and Gliosarcoma.

Case reports in oncology
2021

Do gliosarcomas have distinct imaging features on routine MRI?

The neuroradiology journal
2021

First extensive study of silver-doped lanthanum manganite nanoparticles for inducing selective chemotherapy and radio-toxicity enhancement.

Materials science &amp; engineering. C, Materials for biological applications
2021

Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.

BMC cancer
2021

Analysis of the effects of Photodynamic therapy with Photodithazine on the treatment of 9l/lacZ cells, in vitro study.

Photodiagnosis and photodynamic therapy
2021

Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.

BMC pediatrics
2021

Hypermutated phenotype in gliosarcoma of the spinal cord.

NPJ precision oncology
2024

Primary and secondary gliosarcoma: differences in treatment and outcome.

British journal of neurosurgery
2021

Recurrent metastatic lung gliosarcoma diagnosed by EUS-guided fine-needle biopsy.

Endoscopic ultrasound
2020

IDH1-mutant primary intraventricular gliosarcoma: Case report and systematic review of a rare location and molecular profile.

Surgical neurology international
2021

Gliosarcoma with Adenoid and Chondrosarcomatous Differentiation: A Case Report.

Iranian journal of pathology
2023

Insular glioblastoma: surgical challenges, survival outcomes and prognostic factors.

British journal of neurosurgery
2020

An audit of brain tumor patients treated in 5 years at a single institute: Our regional cancer center experience.

Journal of cancer research and therapeutics
2020

Multiple pathological components in gliosarcoma.

Journal of biomedical research
2021

Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients.

Journal of pediatric hematology/oncology
2021

Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.

Clinical neurology and neurosurgery
2021

Treatments of gliosarcoma of the brain: a systematic review and meta-analysis.

Acta neurologica Belgica
2020

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.

Acta neuropathologica communications
2020

Surgery in High-Grade Insular Tumors: Oncological and Seizure Outcomes from 41 Consecutive Patients.

Asian journal of neurosurgery
2020

Innovative high-resolution microCT imaging of animal brain vasculature.

Brain structure &amp; function
2020

Bumpy head, unusual gliosarcoma metastasis.

Surgical neurology international
2020

A practical method for multimodal registration and assessment of whole-brain disease burden using PET, MRI, and optical imaging.

Scientific reports
2020

Synthesis, Radiolabeling, and Biological Evaluation of the cis Stereoisomers of 1-Amino-3-Fluoro-4-(fluoro-18F)Cyclopentane-1-Carboxylic Acid as PET Imaging Agents.

Journal of medicinal chemistry
2020

Characterization and Histological Examination of a Rare Giant Cell Glioblastoma.

Cureus
2020

Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.

Clinical neurology and neurosurgery
2020

Dural-based atypical teratoid/rhabdoid tumor in an adult: DNA methylation profiling as a tool for the diagnosis.

CNS oncology
2020

Retrobulbar chlorpromazine injection in a child with gliosarcoma invasion into the orbits.

BMJ case reports
2020

Primary pediatric cerebellar gliosarcoma.

Surgical neurology international
2020

Toward personalized synchrotron microbeam radiation therapy.

Scientific reports
2020

Neuroinflammation After Stereotactic Radiosurgery-Induced Brain Tumor Disintegration Is Linked to Persistent Cognitive Decline in a Mouse Model of Metastatic Disease.

International journal of radiation oncology, biology, physics
2020

99mTc-CXCR4-L for Imaging of the Chemokine-4 Receptor Associated with Brain Tumor Invasiveness: Biokinetics, Radiation Dosimetry, and Proof of Concept in Humans.

Contrast media &amp; molecular imaging
2020

Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.

BMC neurology
2020

Primary Gliosarcoma with Extracranial Metastasis.

Brain tumor research and treatment
2020

Update on Circumscribed Gliomas and Glioneuronal Tumors.

Surgical pathology clinics
2020

Gliosarcoma case report and review of the literature.

The Pan African medical journal
2019

Angiosarcomatous component in gliosarcoma: case report and consideration of diagnostic challenge and hemorrhagic propensity.

Journal of biomedical research
2020

Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.

Frontiers in oncology
2021

The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.

Neurosurgical review
2020

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.

Cancer
2020

Analysis of the effect of photodynamic therapy with Fotoenticine on gliosarcoma cells.

Photodiagnosis and photodynamic therapy
2020

Gliosarcomas: magnetic resonance imaging findings.

Arquivos de neuro-psiquiatria
2020

Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma.

Acta neuropathologica communications
2019

Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.

Frontiers in oncology
2020

A rare case of BRAF V600E-mutated epithelioid glioblastoma with a sarcomatous component.

Pathology international
2020

Molecular and clonal evolution in recurrent metastatic gliosarcoma.

Cold Spring Harbor molecular case studies
2020

A simple approximation for the evaluation of the photon iso-effective dose in Boron Neutron Capture Therapy based on dose-independent weighting factors.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
2020

Prognostic factors and clinical outcomes in adult primary gliosarcoma patients: a Surveillance, Epidemiology, and End Results (SEER) analysis from 2004 to 2015.

British journal of neurosurgery
2019

Multi-layered core-sheath fiber membranes for controlled drug release in the local treatment of brain tumor.

Scientific reports
2020

The Coexistence of Gliosarcoma and Arteriovenous Malformation with the BRAF V600E Mutation.

World neurosurgery
2019

Cerebral gliosarcoma with perivascular involvement in a cat.

JFMS open reports
2019

Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT.

Clinical nuclear medicine
2019

Multiple Extracranial Metastases from Primary Gliosarcoma in a Patient with Two Previous Different Primary Cancers.

Case reports in oncological medicine
2020

Clinical implications of multiple glioblastomas: An analysis of prognostic factors and survival to distinguish from their single counterparts.

Journal of the Formosan Medical Association = Taiwan yi zhi
2019

Prognostic factors among single primary gliosarcoma cases: A study using Surveillance, Epidemiology, and End Results data from 1973-2013.

Cancer medicine
2019

Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.

Journal for immunotherapy of cancer
2019

Primary Gliosarcoma of the Cerebellum in a Young Pregnant Woman: Management Challenges and Immunohistochemical Features.

Case reports in surgery
Ver todos os 556 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Gliossarcoma.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Gliossarcoma

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Clinical and molecular features of primary gliosarcoma with digital spatial whole-transcriptome analysis of glial and mesenchymal components.
    Brain pathology (Zurich, Switzerland)· 2026· PMID 41850880mais citado
  2. Gliosarcoma: A Reappraisal of Neuroradiological, Surgical, Morphological, and Radiotherapeutic Characteristics of a Cohort From South Italy Single-Center.
    Analytical cellular pathology (Amsterdam)· 2026· PMID 41810935mais citado
  3. Molecular analysis of a gliosarcoma with distinct oligodendroglioma and sarcomatous components ("Oligosarcoma").
    Brain tumor pathology· 2026· PMID 41838313mais citado
  4. Gliosarcoma of the right cerebellar hemisphere and parahippocampal region: A case report and literature review.
    Oncology letters· 2026· PMID 41797885mais citado
  5. Gelatin hydrogel cross-linked with glutaraldehyde loaded with methylene blue for photodynamic action in gliosarcoma strain 9&#xa0;L/lacZ.
    Journal of biomaterials applications· 2026· PMID 41770081mais citado
  6. Dual-ligand curcin-loaded hybrid solid lipid nanoparticles achieve durable gliosarcoma remission while preserving neuro-behavioral function.
    Theranostics· 2026· PMID 41993637recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:251576(Orphanet)
  2. MONDO:0016681(MONDO)
  3. GARD:5653(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q609503(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Gliossarcoma
Compêndio · Raras BR

Gliossarcoma

ORPHA:251576 · MONDO:0016681
Prevalência
<1 / 1 000 000
Herança
Not applicable
CID-10
C71.9 · Neoplasia maligna do encéfalo, não especificado
CID-11
Ensaios
33 ativos
Início
Adult
Prevalência
0.03 (Europe)
MedGen
UMLS
C0206726
EuropePMC
Wikidata
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades